Guidance

Evidence-based recommendations on irreversible electroporation for treating pancreatic cancer. This involves inserting special needles into the tumour in the pancreas. Short electrical pulses of a high voltage current are then passed through the needles. The aim is to destroy the cancer cells.

Next review: April 2020

Guidance development process

How we develop NICE interventional procedures guidance

Coding and clinical classification codes for this guidance

This guidance replaces NICE interventional procedures guidance on irreversible electroporation for treating pancreatic cancer (IPG442).

Endorsing bodies

This interventional procedures guidance is endorsed by Healthcare Improvement Scotland as required by the Health and Social Care Act (2012).

  • National Institute for Health and Care Excellence (NICE)